MedPath

Michael Scharl

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy

Not Applicable
Completed
Conditions
Fecal Microbiota Transplantation
Cancer
Immunotherapy
Immune Checkpoint Inhibitors
Interventions
Biological: Fecal Microbiota Transplantation (FMT)
First Posted Date
2022-03-10
Last Posted Date
2025-03-28
Lead Sponsor
Michael Scharl
Target Recruit Count
18
Registration Number
NCT05273255
Locations
🇨🇭

University of Zurich, University Hospital Zurich, Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath